Peptide p-nitroanilide substrates and peptidylchloromethane inhibitors were used to examine the specificity of activated human Protein C. Substrates with arginine in the P1 position had the highest activity. The best substrates and inhibitors, as judged by the second-order rate constant for their interaction with the enzyme, had an apolar residue in the P2 position. In contrast with thrombin [Kettner & Shaw (1981) Methods [826][827][828][829][830][831][832][833][834][835][836][837][838][839][840][841][842], activated Protein C was able to accommodate large hydrophobic residues such as phenylalanine and leucine in the P, position. In the P3 position, the enzyme preferred an apolar D-amino acid residue. The results of the present study have also indicated a suitable substrate and inhibitor to be used in the assay of functional protein C and of thrombomodulin.
Peptide p-nitroanilide substrates and peptidylchloromethane inhibitors were used to examine the specificity of activated human Protein C. Substrates with arginine in the P1 position had the highest activity. The best substrates and inhibitors, as judged by the second-order rate constant for their interaction with the enzyme, had an apolar residue in the P2 position. In contrast with thrombin [Kettner & Shaw (1981) Methods [826] [827] [828] [829] [830] [831] [832] [833] [834] [835] [836] [837] [838] [839] [840] [841] [842] , activated Protein C was able to accommodate large hydrophobic residues such as phenylalanine and leucine in the P, position. In the P3 position, the enzyme preferred an apolar D-amino acid residue. The results of the present study have also indicated a suitable substrate and inhibitor to be used in the assay of functional protein C and of thrombomodulin.
Protein C appears to play an important role in the regulation of blood coagulation (Esmon, 1983) . Activated Protein C inhibits coagulation by inactivating Factors V and VIII (Kisiel et al., 1977; Vehar & Davie, 1980; Malar et al., 1982) . The importance of Protein C is indicated by the fact that low concentrations of Protein C are associated with recurrent familial thrombosis (Griffin et al., 1981; Bertina et al., 1982) .
Protein C circulates in plasma as a two-chain zymogen (Kisiel, 1979) that is slowly activated by thrombin alone, but is much more rapidly activated by thrombin in the presence of an endothelial-cell cofactor called thrombomodulin (Esmon et al., 1982; Salem et al., 1984) . Additionally, Factor Va is a less efficient cofactor in the activation reaction (Salem et al., 1983a,b) .
Despite the proposed importance for Protein C in the regulation of coagulation, very little is known about the substrate specificity of activated human Protein C with respect to its natural or synthetic substrates. In the current study, we have determined the kinetic parameters of commercially available peptide p-nitroanilide substrates with human activated Protein C. These experiments yielded information on substrate specificity of the enzyme. The specificity of the enzyme was further examined by determining the kinetics of its Abbreviations used: (in sequences): < Glu, 5-oxopyrrolidine-2-carboxylic acid: Pip, pipecolyl; APro, 3, dehydroproline; Suc, 3-carboxypropionyl, Tos, toluenep-sulphonyl; Bz, benzoyl; Cbz, benzyloxycarbonyl: Nan, p-nitroanilide.
inactivation by a number of peptidylchloromethane inhibitors.
Experimental

Materials
Peptide p-nitroanilide substrates with the nomenclature 'Chromozym' were obtained from Boehringer Biochemicals, Tutzing, Germany, and those with the 'S-****' nomenclature were from AB Kabi, Molndal, Sweden. Peptidylchloromethanes were generously provided by Dr. E. Shaw. Snake venom from OxY uranus scutellatus was from Sigma Chemical Co., St. Louis, MO, U.S.A., and frozen rabbit lungs were supplied by Pel-Freez, Rogers, AR, U.S.A. Fresh or fresh-frozen human plasma was provided by the Blutspendezentrum, Basel, Switzerland. All other chemicals were of the highest purity available commercially.
Preparation of activated Protein C Protein C and prothrombin were purified from human plasma by the methods of Suzuki et al. (1983) and Miletich et al. (1981) respectively.
Thrombomodulin was isolated from frozen rabbit lungs (Esmon et al., 1982) . Prothrombin was activated to thrombin with the venom from 0.
scutellatus (Owen & Jackson, 1973) and purified on SP-(sulphopropyl-)Sephadex (Lundblad, 1971) . Protein C was activated by human thrombin in the presence of rabbit thrombomodulin (Salem et al., 1984) and purified by the method of Kisiel & Davie (1981) .
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Assay of activated Protein C The rate of peptide p-nitroanilide hydrolysis was determined by using a Shimadzu UV240 spectrophotometer to measure the increase in absorbance at 405nm that resulted from the release of pnitroaniline. The reactions were performed in polystyrene cuvettes at 37°C in 50mM-Tris/HCl buffer, pH7.8, containing 0.1 M-NaCl, 0.1% poly-(ethylene glycol) (Mr 6000) and 1.OmM-CaCl2. Activated Protein C was present in the assays at concentrations of 2-200nM. Under the assay conditions, activated Protein C was stable for at least 10min, as determined by the progress-curve method of Selwyn (1965) . An absorption coefficient of 9920M-cm-' at 405 nm for p-nitroaniline was used in the calculation of the amount of product formed . The concentration of the peptide p-nitroanilide substrates was determined spectrophotometrically at 342 nm by using an absorption coefficient of 8270M--cm-' .
In experiments that examined the activity of activated Protein C with various peptide pnitroanilide substrates, the substrate was varied over a 9-fold range. Five different initial substrate concentrations were used, and each point was measured in duplicate.
In experiments that examined the inhibitory effects of peptidylchloromethanes, the substrate S-2238 was present at a concentration of 400fM. The inhibitor was added immediately before the assay was started by the addition of the enzyme. In the absence of inhibitors, the rate of product formation was linear up to a product concentration of greater than 10pM, which represents 2.5% substrate utilization. In the presence of inhibitor, the reaction was allowed to proceed until the amount of product formed was 10pM or until the activity of the enzyme was negligible. Ten data points were taken for analysis from each curve at approximately equal increments of product formation.
Determination of the concentration of activated Protein C
The concentration of activated Protein C was determined by active-site titration with methylumbelliferyl p-guanidinobenzoate by the method of Jameson et al. (1973) . This method assumes that the concentration of titrant is sufficient to saturate the enzyme; and, under these conditions, the amplitude of the initial burst is equal to the concentration of the active enzyme. Activated Protein C was not, however, saturated with the concentrations of the titrant routinely used (10 gM).
Therefore the amplitude of the initial burst that occurred before a steady-state turnover was measured at a number of titrant concentrations and extrapolation was made to infinite concentration. The concentration of activated Protein C was taken to be equal to the calculated amplitude of the initial burst at infinite titrant concentration. The concentration of activated Protein C calculated in this manner agreed well with that based on the absorbance of the enzyme solution at 280nm (Kisiel, 1979) .
Data analysis
For initial-velocity experiments in which the velocity was hyperbolically dependent on the substrate concentration, the data were fitted to the Michaelis-Menten equation by weighted nonlinear regression (Duggleby, 1981) . The weighting used assumed proportional errors (Cornish-Bowden, 1977) , and, in addition, bisquare weighting was included to mitigate the effect of outliers as recommended by Mosteller & Tukey (1977) . For some substrates, velocity was directly proportional to substrate concentration, and for these substrates the second-order rate constant V/Km was determined by weighted linear regression.
The irreversible inhibition of an enzyme in the presence of a substrate can be represented by the following scheme:
where EI* is the irreversibly inactivated enzyme. If it is assumed that substrate and inhibitor binding are in rapid equilibrium and that the substrate concentration does not change significantly during the course of the assay, the concentration of product, [PI, at time t after the initiation of the reaction will be given by eqn.
(1) (Walker & Elmore, 1984; Tian & Tsou, 1982) : 
and d is a displacement term to account for the fact that at t = 0 the absorbance is not accurately known. Progress curves for the inactivation of activated Protein C by peptidylchloromethanes were fitted by non-linear regression to eqn.
(1). (Fersht, 1977) , and values of this parameter for thrombin are given for comparison in Table 1 . With activated Protein C, values obtained for V/Km varied by four orders of magnitude, from 3.3 x 105 M-I S-1 for DIle-Pro-Arg-Nan to less than 1OM-I m S-I for < GluPro-Val-Nan and MeOSuc-Arg-Pro-Lys-Nan. The preference of the enzyme for an arginine residue in the P1 position is clear from the data of Table 1 .
Under the assay conditions used <Glu-Pro-ValNan was not cleaved and substrates with lysine in the P1 position were in general cleaved poorly. There were two substrate pairs that differed only in their P1 residue: Tos-Gly-Pro-Arg/Lys-Nan (Chromozym TH and PL) and D-Val-Leu-Arg/LysNan (S-2266 and S-2251). For these two substrate pairs, the value of V/Km for the arginine derivatives were 17-fold and 316-fold higher respectively. It may be noted that the substitution of lysine for arginine in Tos-Gly-Pro-Arg-Nan caused a decrease in Km as well as a decrease in V. Activated Protein C appears to prefer a bulky non-polar amino acid residue in the P2 position. For thrombin, the best p-nitroanilide substrates have a proline in this position (Lottenberg et al., 1981 . Such substrates were also among the best for activated Protein C, but it was also able to accommodate much larger residues, such as phenylalanine and leucine, in the P2 position (Table 1) . Cho et al. (1984) have also shown that phenylalanine is preferred to glycine in the P2 position of tripeptide p-nitroanilide substrates by activated human Protein C. In the same study, phenyl alanine was a preferred residue in the P2 position of dipeptide thioester substrates. In its preference for phenylalanine in the P2 position, activated Lottenberg et al. (1981) . t AB Kabi, manufacturer's literature. $ Value for bovine thrombin . § No activity was observed with 400,UM substrate and 200 nM enzyme; V/Km can be assumed to be less than IOM-' .m s 1The Km was greater than 200QuM and the velocity appeared to be directly proportional to substrate concentration.
Protein C is similar to kallikreins (Lottenberg et al., 1981) . Thrombin, in contrast, cleaves substrates with phenylalanine in the P2 position relatively poorly (Table 1) .
With activated human Protein C the best substrates yielded a V/Km value of about 1l0M-sI 1 whereas with thrombin the best values were in excess of 107M-' S-1 (Table 1 ). Thus it should be possible to obtain better synthetic substrates for activated Protein C. Any improvement in the value of V/Km for substrates of activated Protein C is likely to be achieved by decreasing the value of Km rather than by increasing V. In comparison with the best substrates for thrombin, the best substrates for activated Protein C yielded similar values for V, but the values for Km were two orders of magnitude larger (Lottenberg et al., 1981) .
Protein C circulates in plasma as a zymogen (Esmon, 1983) , and in order to measure the concentration of functional Protein C it must first be activated by thrombin (Sala et al., 1984; Comp et al., 1984) . Thrombin must subsequently be inactivated before activated Protein C is measured. The assay of the endothelial-cell cofactor thrombomodulin involves the same procedure (Esmon et al., 1982; Salem et al., 1984 ). An ideal substrate for activated Protein C in these assays would have a much higher activity with activated Protein C than with thrombin at concentrations of both that are present in the assay. With such a substrate, incomplete inactivation of thrombin would not produce significant error. If the difference in activities were large enough, the thrombininactivation step could be omitted in the assay of functional Protein C. From the data presented in Table 1 , D-Val-Leu-Arg-Nan (S-2266) would appear to be the best available substrate for this purpose. Protein C and thrombomodulin assays usually contain thrombin at a concentration of about 1% of that of Protein C. At these concentrations, hydrolysis of S-2266 by thrombin is negligible in comparison with that of activated Protein C at all but the lowest extents of Protein C conversion. In fact, if S-2266 is used in the Protein C assay, only a slight increase in background absorbance is observed if the thrombin inactivation step is omitted.
Inactivation of human activated Protein C by peptidylchloromethanes Twenty peptidylchloromethanes were tested as inhibitors by using a continuous assay. The data from a typical experiment are shown in Fig. 1 , and the results obtained for all the inhibitors tested are given in Table 2 . The inhibitors tested could be divided into three major classes: 1, inhibitors with a proline in the P2 position, which had been Table 2 . For the sake of clarity, data obtained at times less than 1 .0min are not included in the Figure. designed as inhibitors of thrombin; 2, inhibitors with a phenylalanine in the P, position, which had been designed as inhibitors of kallikreins; 3, inhibitors with glycine in the P2 position, which had been designed as inhibitors of Factor Xa. In addition, several other compounds were tested. Inhibitors with glycine in the P2 position failed to inactivate the enzyme. With the slightly larger residue alanine in the P2 position inhibition was observed (Table 2) . Thrombin inhibitors with a proline in the P2 position were among the best inhibitors of activated Protein C. Similar results have been obtained by Lijen et al. (1984) . Unlike thrombin, however, activated Protein C seems to be able to accommodate the more bulky phenylalanine residue in the P2 position. Thus, for activated Protein C, D-Phe-Pro-Arg-CH2Cl and DPhe-Phe-Arg-CH2Cl yielded the same apparent second-order rate constant for the inactivation (kI/Ki = 3.7 x 103 M-' I s-1 ). In contrast, for bovine thrombin D-Phe-Pro-Arg-CH2Cl yielded a rate constant 1500-fold larger (Kettner & Shaw, 1981) . A compound with leucine in the P2 position is also a satisfactory inhibitor of activated Protein C ( Table 2) . The importance of a D-amino acid in the P3 position is seen by comparing the values of kl/Ki for the two isomers of Phe-Phe-Arg-CH2Cl; the Disomer is 31-fold more active than the L-isomer, and the increase in the second-order rate constant with the D-isomer is due entirely to a decrease in the binding constant ( Table 2 ). The best substrates for activated Protein C also have D-amino acid residues in the P3 position (Table 1 ). Similar observations have been made with thrombin (Kettner & Shaw, 1981; .
The compound Bz-Ala-D-Phe-Pro-Arg-CH2Cl is interesting from the point of view of the assay of Protein C and thrombomodulin. This compound is a very effective inhibitor of human thrombin, yielding a value of 3.8 x 1OMm-.s-1 for ki/K (Walker et al., 1985) . In contrast, the value of ki/Ki for this compound with human activated Protein C was less than 2GM-1I -s. As discussed above, the assay for Protein C and thrombomodulin requires that thrombin be inactivated after the first stage. Bz-Ala-D-Phe-Pro-Arg-CH,Cl would be a most suitable compound for this purpose. At a concentration of lO2UM thrombin would be inactivated within seconds, whereas the half-life for inactivation of activated Protein C would be greater than 100 min.
